On ECHEMI
Home > Drugs > Shenyang EverBright Pharmaceutical Co., Ltd.
Shenyang EverBright Pharmaceutical Co., Ltd.
  • Founded in:

    1999-01-22
  • Country:

    China China
  • Address:

    No. 31, Songhuahu Street, Shenyang Economic and Technological Development Zone
  • Tax NO.:

    912101064107084581
  • Registered Funds:

    8.82 million yuan
  • Website:

  • Email:

Related Drugs
Cyclic Adenosine Monophosphate for Injection
Cyclic AMP
Name Description Content CAS NO. Registered Holders
Cyclic AMP

It is a protein kinase activator and a derivative of nucleotides. It is an important substance with physiological activity that is widely present in the human body. It is produced by adenosine triphosphate under the catalysis of adenylate cyclase and can regulate various functional activities of cells. As the second messenger of hormones, it plays a role in regulating physiological functions and material metabolism in cells, can change the function of cell membranes, promote calcium ions in reticulum to enter muscle fibers, thereby enhancing myocardial contraction, and can promote the activity of respiratory chain oxidases, improve myocardial hypoxia, relieve symptoms of coronary heart disease and improve electrocardiograms. In addition, it plays an important role in regulating sugar, fat metabolism, nucleic acid, and protein synthesis.

More

It is a protein kinase activator and a derivative of nucleotides. It is an important substance with physiological activity that is widely present in the human body. It is produced by adenosine triphosphate under the catalysis of adenylate cyclase and can regulate various functional activities of cells. As the second messenger of hormones, it plays a role in regulating physiological functions and material metabolism in cells, can change the function of cell membranes, promote calcium ions in reticulum to enter muscle fibers, thereby enhancing myocardial contraction, and can promote the activity of respiratory chain oxidases, improve myocardial hypoxia, relieve symptoms of coronary heart disease and improve electrocardiograms. In addition, it plays an important role in regulating sugar, fat metabolism, nucleic acid, and protein synthesis.

60-92-4 12
Enoxacin Gluconate for Injection
The main ingredient of this product is enoxacin gluconate. Its chemical name is: 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid-D-gluconate monohydrate.
Name Description Content CAS NO. Registered Holders
ENOXACIN GLUCONATE

It has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria, and has antibacterial effects on most bacteria of the Enterobacteriaceae family, penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella, Pseudomonas aeruginosa, etc. It has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial effects on Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. It acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

It has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria, and has antibacterial effects on most bacteria of the Enterobacteriaceae family, penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella, Pseudomonas aeruginosa, etc. It has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial effects on Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. It acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

104142-71-4 26
Enoxacin Gluconate for Injection
The main ingredient of this product is enoxacin gluconate. Its chemical name is: 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid-D-gluconate monohydrate.
Name Description Content CAS NO. Registered Holders
ENOXACIN GLUCONATE

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

104142-71-4 26
Dexamethasone Sodium Phosphate for Injection
The main ingredients of this product and its chemical name: The main ingredient of this product is dexamethasone sodium phosphate. Its chemical name is: 16alpha;-methyl-11beta;,17alpha;,21-trihydroxy-9alpha;-fluoropregnane-1,4-diene-3,20-dione-21-phosphate disodium salt. Its molecular formula: C22H28FNa2O8P, molecular weight: 516.41.
Name Description Content CAS NO. Registered Holders
Dexamethasone sodium phosphate

Adrenal cortex hormone drugs. It has anti-inflammatory, anti-allergic, anti-rheumatic and immunosuppressive effects. 1. Anti-inflammatory effect: This product reduces and prevents tissue response to inflammation, thereby reducing the manifestations of inflammation. It can inhibit the accumulation of inflammatory cells, including macrophages and leukocytes at the site of inflammation, and inhibit phagocytosis, the release of lysosomal enzymes, and the synthesis and release of inflammatory chemical mediators. 2. Immunosuppressive effect: including preventing or inhibiting cell-mediated immune responses, delayed allergic reactions, reducing the number of T lymphocytes, monocytes, and eosinophils, reducing the ability of immunoglobulins to bind to cell surface receptors, and inhibiting the synthesis and release of interleukins, thereby reducing the transformation of T lymphocytes into lymphoblasts and reducing the expansion of primary immune responses. This product also reduces the passage of immune complexes through the basement membrane and can reduce the concentration of complement components and immunoglobulins.

More

Adrenal cortex hormone drugs. It has anti-inflammatory, anti-allergic, anti-rheumatic and immunosuppressive effects. 1. Anti-inflammatory effect: This product reduces and prevents tissue response to inflammation, thereby reducing the manifestations of inflammation. It can inhibit the accumulation of inflammatory cells, including macrophages and leukocytes at the site of inflammation, and inhibit phagocytosis, the release of lysosomal enzymes, and the synthesis and release of inflammatory chemical mediators. 2. Immunosuppressive effect: including preventing or inhibiting cell-mediated immune responses, delayed allergic reactions, reducing the number of T lymphocytes, monocytes, and eosinophils, reducing the ability of immunoglobulins to bind to cell surface receptors, and inhibiting the synthesis and release of interleukins, thereby reducing the transformation of T lymphocytes into lymphoblasts and reducing the expansion of primary immune responses. This product also reduces the passage of immune complexes through the basement membrane and can reduce the concentration of complement components and immunoglobulins.

55203-24-2 24
Dexamethasone Sodium Phosphate for Injection
The main ingredients of this product and its chemical name: The main ingredient of this product is dexamethasone sodium phosphate. Its chemical name is: 16alpha;-methyl-11beta;,17alpha;,21-trihydroxy-9alpha;-fluoropregnane-1,4-diene-3,20-dione-21-phosphate disodium salt. Its molecular formula: C22H28FNa2O8P, molecular weight: 516.41.
Name Description Content CAS NO. Registered Holders
Dexamethasone sodium phosphate

Adrenal cortex hormone drugs. It has anti-inflammatory, anti-allergic, anti-rheumatic and immunosuppressive effects. 1. Anti-inflammatory effect: reduce and prevent tissue response to inflammation, inhibit inflammatory cell aggregation and phagocytosis, lysosomal enzyme release, and synthesis and release of inflammatory chemical mediators; 2. Immunosuppressive effect: prevent or inhibit cell-mediated immune response, reduce the number of T lymphocytes, monocytes, and eosinophils, reduce the ability of immunoglobulins to bind to cell surface receptors and inhibit interleukin synthesis and release, reduce the transformation of T lymphocytes to lymphoblasts and reduce the expansion of primary immune responses, reduce the passage of immune complexes through the basement membrane and reduce complement components and immunoglobulin concentrations.

More

Adrenal cortex hormone drugs. It has anti-inflammatory, anti-allergic, anti-rheumatic and immunosuppressive effects. 1. Anti-inflammatory effect: reduce and prevent tissue response to inflammation, inhibit inflammatory cell aggregation and phagocytosis, lysosomal enzyme release, and synthesis and release of inflammatory chemical mediators; 2. Immunosuppressive effect: prevent or inhibit cell-mediated immune response, reduce the number of T lymphocytes, monocytes, and eosinophils, reduce the ability of immunoglobulins to bind to cell surface receptors and inhibit interleukin synthesis and release, reduce the transformation of T lymphocytes to lymphoblasts and reduce the expansion of primary immune responses, reduce the passage of immune complexes through the basement membrane and reduce complement components and immunoglobulin concentrations.

55203-24-2 24
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.